Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7364 record(s)

Req # A-2022-001486

Adverse Drug Reactions (ADRs). Report numbers: E2B_02121456, E2B_02093591, E2B_05935451, E2B_05887182, E2B_06026557.

Organization: Health Canada

73 page(s)
November 2024

Req # A-2022-001516

Adverse Drug Reactions (ADRs) for ENTYVIO. Report numbers: E2B_06001907, E2B_06017562, E2B_05989083, E2B_06030605, E2B_05975424, E2B_06010484, E2B_06028666, E2B_05996872, E2B_05978116, E2B_06024257.

Organization: Health Canada

142 page(s)
November 2024

Req # A-2022-001555

Adverse Drug Reactions (ADRs). Report numbers: 001020134, 001022815, E2B_05985461, E2B_05997808, E2B_06024320.

Organization: Health Canada

92 page(s)
November 2024

Req # A-2023-000292

Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03132734, E2B_03147294, E2B_03113384, E2B_03138585, E2B_00327688, E2B_03233229. ADRs for VARIVAX III. Report numbers: E2B_02804158, 000679874. ADRs for ZOLINZA. Report numbers:…

Organization: Health Canada

106 page(s)
November 2024

Req # A-2023-000335

Adverse Drug Reactions (ADRs) for DEXILANT. Report numbers: E2B_06227430, E2B_06248993, 001032323, E2B_06249888. ADRs for ENTYVIO. Report numbers: E2B_06244726, E2B_06237252, E2B_06213586. ADR for IXAZOMIB. Report number: E2B_06242068. ADR for…

Organization: Health Canada

1294 page(s)
November 2024

Req # A-2024-000101

Adverse Drug Reactions (ADRs) for Entyvio. Report numbers: E2B_06954186, 001075329. ADR for Vedolizumab. Report number: 001081570. ADR for Nesina. Report number: 001081180. ADR for Ixazomib. Report number: E2B_06922374. ADRs for Ondansetron.…

Organization: Health Canada

185 page(s)
November 2024

Req # A-2024-000181

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108758-44.

Organization: Health Canada

19 page(s)
November 2024

Req # A-2024-000200

Adverse Drug Reactions (ADRs). Report numbers: 001081963, 001082532, 001081570, 001082478, 001075295, E2B_06959022, E2B_06850099, E2B_06931413, E2B_06938467, 001076647.

Organization: Health Canada

12 page(s)
November 2024

Req # A-2024-000217

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-100656-5, Letter to British Columbia's Minister of Mental Health and Addictions Regarding Personal Possession Exemption.

Organization: Health Canada

25 page(s)
November 2024

Req # A-2024-000218

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-112221-455.

Organization: Health Canada

15 page(s)
November 2024
Date modified: